LTFS
SUPN icon

Ladenburg Thalmann Financial Services’s Supernus Pharmaceuticals SUPN Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$72K Buy
3,015
+2,496
+481% +$60.6K ﹤0.01% 3276
2019
Q3 		$15K Sell
519
-610
-54% -$18.1K ﹤0.01% 4199
2019
Q2 		$37K Sell
1,129
-55
-5% -$1.88K ﹤0.01% 3657
2019
Q1 		$42K Sell
1,184
-237
-17% -$8.82K ﹤0.01% 3526
2018
Q4 		$47K Buy
1,421
+655
+86% +$28.2K ﹤0.01% 3302
2018
Q3 		$39K Sell
766
-1,189
-61% -$58.7K ﹤0.01% 3490
2018
Q2 		$90K Hold
1,955
– – ﹤0.01% 2812
2018
Q1 		$90K Buy
1,955
+374
+24% +$15.6K ﹤0.01% 2812
2017
Q4 		$64K Sell
1,581
-275
-15% -$10.9K ﹤0.01% 3059
2017
Q3 		$75K Sell
1,856
-214
-10% -$9.26K ﹤0.01% 2792
2017
Q2 		$89K Sell
2,070
-474
-19% -$16.9K ﹤0.01% 2592
2017
Q1 		$80K Sell
2,544
-321
-11% -$8.6K ﹤0.01% 2556
2016
Q4 		$72K Buy
2,865
+147
+5% +$3.29K ﹤0.01% 2574
2016
Q3 		$66K Sell
2,718
-1,016
-27% -$23K ﹤0.01% 2574
2016
Q2 		$76K Buy
3,734
+44
+1% +$780 ﹤0.01% 2360
2016
Q1 		$56K Buy
3,690
+1,482
+67% +$19.3K ﹤0.01% 2511
2015
Q4 		$30K Sell
2,208
-443
-17% -$6.85K ﹤0.01% 2940
2015
Q3 		$37K Buy
2,651
+25
+1% +$465 ﹤0.01% 2672
2015
Q2 		$45K Buy
2,626
+1,415
+117% +$20.1K ﹤0.01% 2655
2015
Q1 		$15K Hold
1,211
– – ﹤0.01% 3377
2014
Q4 		$10K Hold
1,211
– – ﹤0.01% 3429
2014
Q3 		$11K Hold
1,211
– – ﹤0.01% 3055
2014
Q2 		$13K Buy
1,211
+211
+21% +$1.88K ﹤0.01% 2948
2014
Q1 		$9K Hold
1,000
– – ﹤0.01% 3024
2013
Q4 		$8K Buy
+1,000
New +$6.99K ﹤0.01% 3060

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ladenburg Thalmann Financial Services's SUPN Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Supernus Pharmaceuticals (SUPN) stake by 481% in Q4 2019, buying an estimated $60.6K and bringing the position to 3,015 shares worth $72K. The position accounts for ﹤0.01% of the portfolio, ranked #3276.

Ladenburg Thalmann Financial Services first reported a position in SUPN in Q4 2013 and has held it in 25 quarters since. The position peaked at $90K in Q2 2018. 235 funds tracked by Wall St. Rank hold SUPN as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 3,015 shares of Supernus Pharmaceuticals worth $72K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 2,496 Supernus Pharmaceuticals shares in Q4 2019, an estimated $60.6K.
  • Supernus Pharmaceuticals made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3276 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Supernus Pharmaceuticals in Q4 2013 and has held it in 25 quarters since.
  • Ladenburg Thalmann Financial Services's Supernus Pharmaceuticals position peaked at $90K in Q2 2018.
  • 235 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.